Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

Robert H. Vonderheide, Kimberly A. Kraynyak, Anthony F. Shields, Autumn J. McRee, Jennifer M. Johnson, Weijing Sun, Ashish V. Chintakuntlawar, Jan Pawlicki, Albert J. Sylvester, Trevor McMullan, Robert Samuels, Joseph J. Kim, David Weiner, Jean D. Boyer, Matthew P. Morrow, Laurent Humeau, Jeffrey M. Skolnik

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences